Mission Bio

About:

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

Website: http://www.missionbio.com

Twitter/X: missionbio

Top Investors: Alumni Ventures, National Science Foundation, Novo Holdings, Agilent Technologies, National Institutes of Health

Description:

Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation.